It’s not what you get, it’s what you keep could be an idiom that applies directly to imaging technology.
It's not what you get, it's what you keep could be an idiom that applies directly to imaging technology.
For years, ultrasound had been throwing away data, information buried in the returning echo signal, because physicists didn't know what to do with it. One day, the light bulb went on above someone's head, and slow-flow imaging was born.
The same process may now be happening in CT.
GE Healthcare will describe today at the International Symposium on Multidetector-Row CT early work to develop a new kind of CT detector that does more than count individual photons. This detector, already in the prototype stage and generating phantom images, translates photon strikes into anatomic position and material characteristics. Among the possible distinctions it will try to make are contrast media, calcifications, and bone versus soft tissue, particularly blood vessel walls.
"Ultimately, we want to use the same x-ray beam, discerning from it what the (body) materials are, in a way that doesn't overexpose patients to dose," said Gene Saragnese, global vice president of molecular imaging and CT at GE Healthcare. "So we are looking at a technique by which we count the photons and characterize their energies as they come in."
The technique, called spectral CT, focuses on getting as much information from each photon striking the detector as possible, according to Saragnese. Because the signal contains so much information, this particular technique prefers low dose.
"It doesn't work very well if you slam the detector with the kind of flux levels seen in today's CT scanners," said Brian J. Duchinsky, global general manger for GE Healthcare's CT business.
Best of all for the engineers and bean counters at GE, the detector that makes this happen requires standard materials, even though the data harvest is much greater.
"We are the only company thinking that way, at least up to this point," Duchinsky said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.